Independent drug bulletins to promote the prescription of appropriate drugs: A necessary but difficult task

Bulletin of the World Health Organization

Volumn 91, Issue 6, 2013, Pages

  Burnand, Bernard ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

ACCESS TO INFORMATION; CLINICAL TRIAL (TOPIC); CONTINUING EDUCATION; DRUG EFFICACY; DRUG INFORMATION; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; FRANCE; GOVERNMENT; HEALTH CARE PERSONNEL; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; SYSTEMATIC ERROR;

PAMPHLETS; PRESCRIPTION DRUGS;

EID: 84878449825     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.13.122762     Document Type: Editorial

References (11)

1. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60. doi: http://dx.doi.org/10.1056/NEJMsa065779 PMID:18199864
2. Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 2008;5:e217, discussion e217. doi: http://dx.doi.org/10.1371/journal. pmed.0050217 PMID:19067477
3. Djulbegovic B, Kumar A, Glasziou PP, Perera R, Reljic T, Dent L et al. New treatments compared to established treatments in randomized trials. Cochrane Database Syst Rev 2012;10:MR000024. doi: http://dx.doi. org/10.1002/14651858 PMID:23076962
4. Gøtzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 2011;12:249. doi: http://dx.doi. org/10.1186/1745-6215-12-249 PMID:22112900
5. Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 2009;361:1963-71. doi: http://dx.doi.org/10.1056/NEJMsa0906126 PMID:19907043
6. The future of independent drug bulletins. Drug Ther Bull 2012;50:61. doi: http://dx.doi.org/10.1136/dtb.2012.06.0106 PMID:22679242
7. Prescrire.org [Internet]. Prescrire. Paris: Prescrire; 2013. Available from: http://www.prescrire.org/fr/ [accessed 25 April 2013].
8. Mullard A. Mediator scandal rocks French medical community. Lancet 2011;377:890-2. doi: http://dx.doi.org/10.1016/S0140-6736(11)60334-6 PMID:21409784
9. ISDB [Internet]. Paris: International Society of Drug Bulletins; 2013. Available from: www.isdbweb.org [accessed 25 April 2013].
10. Gøtzsche PC. Deficiencies in proposed new EU regulation of clinical trials. BMJ 2012;345:e8522. doi: http://dx.doi.org/10.1136/bmj.e8522 PMID:23258926
11. Song F, Bhurke SP, Hooper L, Loke YK, Ryder JJ, Sutton AJ et al. Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies. BMC Med Res Methodol 2009;9:79.